Tong Ren Tang Technologies' (HKG:1666) attributable profit fell 12% to 521.8 million yuan in 2024 from 590.2 million yuan in 2023, according to a Friday filing with the Hong Kong bourse.
Earnings per share at the traditional Chinese medicine company decreased to 0.41 yuan from 0.46 yuan in the previous year.
Revenue grew 7.2% to 7.26 billion yuan from 6.77 billion yuan a year earlier.
The company declared a final dividend of 0.18 yuan per share, similar to last year's dividend. The dividend will be paid on Aug. 11.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.